Area of Interest
Miscellaneous(1)
Technical Documents(1)
Document Category
Bulletin(3)
General Information(2)
Product Information Sheet(6)

Available for Sale

Search term:"NanoFabTx™"

Compare Products: Select up to 4 products.

*Please select more than one item to compare

11 matches found for NanoFabTx™

NanoFabTx Microfluidic - Nano, device kit Protocol (620 KB)

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. NanoFabTx™ Microfluidic - Nano, device kit Protocol for Catalog No. 911593 Introduction NanoFabTx™ is a set of formulation reagent and device kits from MilliporeSigma designed to effortless...

NanoFabTx Microfluidic - Nano, device kit Protocol (610 KB)

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. NanoFabTx™ Microfluidic - Nano, device kit Protocol for Catalog No. 911593 Introduction NanoFabTx™ is a set of formulation reagent and device kits from MilliporeSigma designed to effortlessly and rapidly synthesize...

911860 Product Information Sheet (556 KB)

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada NanoFabTx TM Microfluidic - micro, device kit for synthesis of 1-5 m particles Protocol for Catalog No. 911860 Introduction NanoFabTx™ is a set of formulation reagent and device kits from MilliporeSigma designed to...

Bulletin (571 KB)

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM Microfluidic - micro, device kit for synthesis of 10-30m particles Protocol for Catalog No. 911879 Introduction NanoFabTx™ is a set of formulation reagent and device kits from MilliporeSigma designed ...

911860 Product Information Sheet (566 KB)

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM Microfluidic - micro, device kit for synthesis of 1-5 m particles Protocol for Catalog No. 911860 Introduction NanoFabTx™ is a set of formulation reagent and device kits from ...

911879 Product Information Sheet (571 KB)

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM Microfluidic - micro, device kit for synthesis of 10-30m particles Protocol for Catalog No. 911879 Introduction NanoFabTx™ is a set of formulation reagent and device kits from MilliporeSigma designed ...

911879 Product Information Sheet (580 KB)

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM Microfluidic - micro, device kit for synthesis of 10-30m particles Protocol for Catalog No. 911879 Introduction NanoFabTx™ is a set of formulation reagent and device kits from...

Product Information Protocol (509 KB)

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM PLGA-Nano, for synthesis of 100 and 200 nm particles Protocol for Catalog No. 909637 Introduction NanoFabTx™ is a set of formulation kits from MilliporeSigma designed to effortlessly and rapidly synthe...

909637 - Product Information Protocol (556 KB)

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. NanoFabTx TM PLGA-Nano, for synthesis of 100 and 200 nm particles Protocol for Catalog No. 909637 Introduction NanoFabTx™ is a set of formulation kits from MilliporeSigma designed to effort...

Material Matters 15.3 (5 MB)

VOLUME 15 • NUMBER 3 Material Matters ™ Advanced Tools for Drug Delivery Research Flash NanoPrecipitation (FNP) – Principles and Applications in Medical Imaging and Drug Delivery Recent Progress on Nonviral Delivery Carriers for CRISPR/Cas9 Systems Smart Nanofiber Meshes as a Local Drug Delivery Pla...

Material Matters 15.3 (5 MB)

VOLUME 15 • NUMBER 3 Material Matters ™ Advanced Tools for Drug Delivery Research Flash NanoPrecipitation (FNP) – Principles and Applications in Medical Imaging and Drug Delivery Recent Progress on Nonviral Delivery Carriers for CRISPR/Cas9 Systems Smart Nanofiber Meshes as a Local Drug Delivery Pla...